Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
Conditions
- Estrogen Receptor Negative
- HER2/Neu Negative
- Progesterone Receptor-negative
- Stage IV Breast Cancer
- Triple-negative Breast Carcinoma
Interventions
- DRUG: everolimus
- DRUG: eribulin mesylate
- OTHER: pharmacological study
- OTHER: laboratory biomarker analysis
Sponsor
City of Hope Medical Center
Collaborators